Nonetheless, several animal and human studies have reported that palmitoleic acid (16:1n-7) may enhance whole-body insulin sensitivity, increase hepatic FA oxidation, and improve blood lipid profile (39), and are associated with a low prevalence of diabetes and cardiovascular risk (9, 40, 41). The gene discussed is INS; the disease is diabetes mellitus.